Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report
The United Kingdom’s approach to CBD regulation is at a historic crossroads. In August 2025, the Food Standards Agency (FSA) took unprecedented steps toward full market authorizations for CBD-containing foods—potentially ending years of regulatory limbo under the interim "CBD public list" system. For manufacturers, importers, and retailers, adapting to these changes will mean a total recalibration of compliance and operational strategy.
This post provides a comprehensive look at the latest developments in the UK FSA CBD novel foods 2025 process, what these mean for your business, and what to expect as the FSA moves toward full product authorizations.
On 28–29 August 2025, the FSA launched a public consultation on authorizing three named CBD-containing foods as novel foods in Great Britain. This is the most concrete step yet towards full, product-specific novel food authorizations since CBD was classified as a "novel food" under EU and subsequently UK law (FSA, August 2025 Consultation Notice).
A novel food authorization is a formal, individualized approval for a specific product, formulation, and manufacturer to market that food in the UK. This is far more rigorous than the interim "public list" allowance, which has let certain CBD items remain on shelves pending full assessment.
From 2019-2025, the UK’s CBD market exploded without clear regulatory certainty. As FSA data and the broader scientific evidence base have grown, pressure mounted from public health stakeholders, industry, and Parliament to move beyond interim arrangements.
Key drivers:
The August 2025 consultation invites comments on three products’ safety dossiers: one CBD isolate powder and two broad-spectrum CBD extracts. These have already passed technical scrutiny and are now under public and stakeholder review.
Brands can expect that all future authorizations will demand:
Enforcement actions will get tougher: products not explicitly authorized will have to be withdrawn from sale. As this regime rolls out into 2026, expect robust monitoring by Trading Standards and FSA inspectors.
The FSA encourages input from industry, healthcare professionals, and the public. The deadline for responses is typically six weeks from launch—exact closing dates and submission instructions are on the FSA consultation portal.
Transitioning from the public list to the full authorization framework won’t be immediate, but businesses must prepare.
Stay tuned to FSA updates and the CBD industry hub for breaking developments.
Every SKU needs full documentation:
Label claims, dosage information, and product form (oil, capsule, edible) must match the wording approved by the FSA’s authorization. Non-compliance could result in withdrawal orders or fines.
Expect requirements to include:
Submit technical input or comment on the FSA’s draft risk assessments—industry voices matter in shaping the final rules.
Enforcement will become more predictable—but also more demanding.
Penalties for non-compliance include:
The UK FSA CBD novel foods 2025 process signals a major shift:
For current and prospective CBD brands, importers, and retailers, now is the time to review compliance strategies, invest in regulatory affairs capacity, and plan for robust supply chain and product safety management.
Stay ahead of FSA compliance and UK CBD regulations: Visit CannabisRegulations.ai for expert insights, updates, and regulatory tools tailored to the CBD and novel foods market.